Signalling pathways involved in the activation of dendritic cells by layered double hydroxide nanoparticles

Biomaterials

Volumn 31, Issue 4, 2010, Pages 748-756

  Li, Ang ^a   Qin, Lili ^a   Zhu, Di ^a   Zhu, Rongrong ^a   Sun, Jing ^a   Wang, Shilong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Dendritic cell; Layered double hydroxides; Nanoparticles; Vaccine

Indexed keywords

CELL ENGINEERING; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; FLOW CYTOMETRY; MOLECULAR BIOLOGY; MOLECULES; NANOPARTICLES; VACCINES;

ANTI-INFLAMMATORIES; DENDRITIC CELLS; DENDRITIC CELLS (DCS); DOSE-DEPENDENT MANNER; FLUORESCENCE ACTIVATED CELL SORTING; HYDRODYNAMIC DIAMETER; INTRACELLULAR ORGANELLE; LAYERED DOUBLE HYDROXIDES;

CELL SIGNALING;

ALUMINUM HYDROXIDE; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOKINE; HYDROXIDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; MAGNESIUM HYDROXIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; VACCINE; B7 ANTIGEN; HYDROXIDE ION;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL NUCLEUS; DEGRADATION; DENDRITIC CELL; ENDOCYTOSIS; EXPOSURE; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE ACTIVATED CELL SORTING; FUTUROLOGY; HYDRODYNAMICS; IMMUNOCOMPETENT CELL; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; UPREGULATION; ZETA POTENTIAL; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; GENE; METABOLISM;

ALUMINUM HYDROXIDE; ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GENES, MHC CLASS II; HYDROXIDES; INTERLEUKIN-12; INTERLEUKIN-6; MAGNESIUM HYDROXIDE; MICE; NANOPARTICLES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75549084605     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.09.095     Document Type: Article

References (41)

1. O'Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003;2:727-35.
2. Seida Y, Nakano Y. Removal of phosphate by layered double hydroxides containing iron. Water Res 2002;36:1306-12.
3. Kwon SJ, Choy JH. A novel hybrid of Bi-based high-Tc superconductor and molecular complex. Inorg Chem 2003;42:8134-6.
4. Tarnawski A, Pai R, Itani R, Wyle FA. The antacid talcid adsorbs and neutralizes all proteins secreted by hpylori including VacA cytotoxin: a new mechanism for its ulcerhealing action. Digestion 1999;60:449-55.
5. Tyner KM, Schiffman SR, Giannelis EP. Nanobiohybrids as delivery vehicles for camptothecin. J Control Release 2004;95:501-14.
6. Choy JH, Jung JS, Oh JM, Park M. Layered double hydroxides as an efficient drug reservoir for folate derivatives. Biomaterials 2004;25:3059-64.
7. Xu ZP, Nieber M, Porazik K, Walker TL, Cooper HM. Subcellular compartment targeting of layered double hydroxide nanoparticles. J Control Release 2008;130:86-94.
8. Qin LL,Wang SL, Zhang R, Zhu RR, Sun XY, Yao SD. Two different approaches to synthesizing Mg-Al-layered double hydroxides as folic acid carriers. J Phys Chem Solids 2008;69:2779-84.
9. Men Y, Audran R, Thomasin C, Eberl G, Demotz S, Merkle HP. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 1999;17:1047-56.
10. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306.
11. Yoshida M, Babensee JE. Poly (lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res 2004;71A: 45-54.
12. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
13. Waeckerle-Men Y, Scandella E, Uetz-Von Allmen E, Ludewig B, Gillessen S, Merkle HP. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods 2004;287:109-24.
14. Wang RF, Wang HY. Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nat Biotechnol 2002;20:149-54.
15. Huth US, Schubert R, Peschka-Suss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bioimaging. J Control Release 2006;110:490-504.
16. Nakano H, Lin KL, Yanagita M. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol 2009;10:394-402.
17. Gupta RK, Rost BE, Relyveld E. Adjuvant properties of aluminum and calcium compounds. J Pharm Biotechnol 1995;6:229-48.
18. Reddy ST, Berk DA, Jain RK, Swartz MA. A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Phys 2006;101:1162-9.
19. Fields RC, Shimizu K, Mulé JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci U S A 1998;95:9482-7.
20. Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002;100:1354-61.
21. Li A, He ML, Wang H. All-trans retinoic acid negatively regulates cytotoxic activities of nature killer cell line 92. Biochem Biophys Res Commun 2007;352:42-7.
22. 2O as a continuous function of nitrate anions. J Phys Chem B 2001;105:1743-9.
23. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-87.
24. Ponsaerts P, Van Tendeloo VF, Berneman ZN. Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol 2003;134:378-84.
25. + T cells. J Immunol 1995;154:5071-9.
26. Gamvrellis A, Leong D, Hanley JC, Xiang SD, Mottram P, Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 2004;82:506-16.
27. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998;393:474-8.
28. Arezoo C, Ellen YY, Mindy T. Pro-inflammatory effects of aluminum in human glioblastoma cells. Brain Res 2002;933:60-5.
29. Oh JM, Choi SJ, Kim ST. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates:enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug Chem 2006;17:1411-7.
30. Frey A, Mantis N, Kozlowski PA. Immunization of mice with peptomers covalently coupled to aluminum oxide nanoaprticle. Vaccine 1999;17:3007-19.
31. Seubert A, Monaci E, Pizza M. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol 2008;180:5402-12.
32. Kool M, Soullie T, van Nimwegen M, Willart MA, Muskens F, Jung S, et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008;205:869-82.
33. Ladi E, Schwickert TA, Chtanova T. Thymocyte-dendritic cell interactions near sources of CCR7 ligands in the thymic cortex. J Immunol 2008;181:7014-23.
34. Perrot I, Blanchard D, Freymond N. Dendritic cells infiltrating human nonsmall cell lung cancer are blocked at immature stage. J Immunol 2007;178:2763-9.
35. Riol-Blanco L, Sanchez-Sanchez N, Torres A, Tejedor A, Narumiya S, Corbi AL. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol 2005;174:4070-80.
36. Sánchez-Sánchez N, Riol-Blanco L, Rodríguez-Fernández JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 2006;176:5153-9.
37. Nakao S, Ogtata Y, Shimizu E. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release ismediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mol Cell Biochem 2002;238:11-8.
38. Huang H, Sakurai F, Higuchi Y. Suppressive effects of sugar-modified cationic liposome/NF-kappaB decoy complexes on adenovirus vector-induced innate immune responses. J Control Release 2009;133:139-45.
39. Tang M, Wei X, Guo Y. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J Exp Med 2008;205:1611-9.
40. Litvak V, Ramsey SA, Rust AG. Function of C/EBP delta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 2009;10:437-43.
41. Mora-Garcia P, Cheng J, Crans-Vargas HN. Transcriptional regulators and myelopoiesis: the role of serum response factor and CREB as targets of cytokine signaling. Stem Cells 2003;21:123-30.